NeuroHagana
Preventing Permanent Disabilities after Neurotrauma
Active
Pre-Funding
Startup
Tel Aviv-Yafo
Founded 2023-03
NeuroHagana (NH) develops an injectable emergency treatment for neurotrauma, irrespective of its type or severity. The novel treatment acts immediately to protect against the main factor in Neurotrauma pathology: Glutamate Excitotoxicity. NH’s technology has been pre-clinically validated in animal models of Spinal Cord Injury, Traumatic Brain Injury, and At…
SectorHealth Tech & Life Sciences
StagePre-Funding
Employees5
Founded2023-03
HQTel Aviv-Yafo
Patents1
Confidence80
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders